GENET-news
To stay informed you can subscribe to the GENET-news list.
2007-03-15 | permalink
European patent on stem cells may be a possibility
As long as the research meets the usual requirements for a patent, isolated embryonic stem cells should be considered for both method and product patents. This conclusion, which runs counter to the views of the European Group on Ethics under the European Commission, was reached by an interdisciplinary group at the Center for Bioethics at the Karolinska Institute and Uppsala University in an academic article in the international journal Stem Cells.
Overview
News
2007-03-15 | permalink
European patent on stem cells may be a possibility
As long as the research meets the usual requirements for a patent, isolated embryonic stem cells should be considered for both method and product patents. This conclusion, which runs counter to the views of the European Group on Ethics under the European Commission, was reached by an interdisciplinary group at the Center for Bioethics at the Karolinska Institute and Uppsala University in an academic article in the international journal Stem Cells.
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.